{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:25:19Z","timestamp":1781123119437,"version":"3.54.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["SJCX22_1276"],"award-info":[{"award-number":["SJCX22_1276"]}]},{"name":"Medical Technology Innovation Project of the Xuzhou Municipal Health Commission","award":["XWKYHT20230072"],"award-info":[{"award-number":["XWKYHT20230072"]}]},{"name":"Construction Project of High Level Hospital of Jiangsu Province","award":["GSPSJ20240805"],"award-info":[{"award-number":["GSPSJ20240805"]}]},{"name":"Advanced Program of The Affiliated Hospital of Xuzhou Medical University","award":["PYJH2025203"],"award-info":[{"award-number":["PYJH2025203"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:p>\n                    This study aims to identify an optimal model for assessing the recurrence frequency of Budd\u2013Chiari syndrome (BCS) and further analyze the factors contributing to BCS recurrence. A total of 754 patients who were admitted to the Affiliated Hospital of Xuzhou Medical University between January 2015 and July 2022 were included. We constructed 4 different count outcome models: Poisson, negative binomial (NB) model, zero-inflated Poisson (ZIP) model, and zero-inflated negative binomial (ZINB) model. We selected the model with the best fitting performance to explore factors associated with BCS recurrence. Of 754 respondents, 511 reported no recurrence. Log-likelihood ratio tests indicated that the NB model performed better than the Poisson regression model (\u03c7\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u2005124.91,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and the ZINB model outperformed the ZIP model (\u03c7\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u200534.29,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). In the ZINB model, the analysis of the counting process revealed that the variables significantly associated with recurrence frequency included age (odds ratio [OR]\u2005=\u20050.69; 95% confidence interval [CI]: 0.57\u20130.84), sex (female: OR\u2005=\u20051.77; 95% CI: 1.24\u20132.55), anticoagulant use (warfarin vs new oral anticoagulants [NOACs]: OR\u2005=\u20052.11, 95% CI: 1.34\u20133.31; not using anticoagulants vs NOACs: OR\u2005=\u20051.98, 95% CI: 1.20\u20133.28), absence of cirrhosis (OR\u2005=\u20050.57, 95% CI: 0.40\u20130.82), and neutrophil count (NEU) (OR\u2005=\u20051.22, 95% CI: 1.04\u20131.42). The zero-inflated model proved robust in identifying factors influencing BCS recurrence compared with the other models. Influence of sex, surgery, anticoagulation, cirrhosis, hospital duration, apolipoprotein A, and NEU on the recurrence risk and frequency of BCS.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045511","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:03:12Z","timestamp":1764169392000},"page":"e45511","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of risk factors for recurrence of Budd\u2013Chiari syndrome: A retrospective study with zero-inflated model"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-0655","authenticated-orcid":false,"given":"Shengli","family":"Li","sequence":"first","affiliation":[{"name":"Clinical Research Institute, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China"},{"name":"School of Computer Science and Technology\/School of Artificial Intelligence, China University of Mining and Technology, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2334-5189","authenticated-orcid":false,"given":"Xiangting","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Xuancheng People\u2019s Hospital, Xuancheng, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9396-1217","authenticated-orcid":false,"given":"Muyao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Jiangsu Normal University, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuocuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Xuancheng People\u2019s Hospital, Xuancheng, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Xuzhou Central Hospital, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0184-307X","authenticated-orcid":false,"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Computer Science and Technology\/School of Artificial Intelligence, China University of Mining and Technology, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Computer Science and Technology\/School of Artificial Intelligence, China University of Mining and Technology, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clinre.2018.10.014","article-title":"Epidemiology of Budd\u2013Chiari syndrome: a systematic review and meta-analysis.","volume":"43","author":"Li","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R3-20260514","first-page":"329","article-title":"Chinese multidisciplinary collaborative expert consensus for the diagnosis and treatment of Budd\u2013Chiari syndrome (2021 version) [in Chinese].","volume":"60","year":"2022","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/ntr\/ntw030","article-title":"Smoking and air pollution as pro-inflammatory triggers for the development of rheumatoid arthritis.","volume":"18","author":"Anderson","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"16166","DOI":"10.1038\/s41598-022-20399-x","article-title":"Evaluation of outcome from endovascular therapy for Budd\u2013Chiari syndrome: a systematic review and meta-analysis.","volume":"12","author":"Mukhiya","year":"2022","journal-title":"Sci Rep"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s10620-020-06485-y","article-title":"An update on the management of Budd\u2013Chiari syndrome.","volume":"66","author":"Sharma","year":"2021","journal-title":"Dig Dis Sci"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/liv.14131","article-title":"Budd\u2013Chiari syndrome in the West and the East: same syndrome, different diseases.","volume":"39","author":"Mancuso","year":"2019","journal-title":"Liver Int"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jvir.2020.08.035","article-title":"Long-term outcomes of endovascular interventions in more than 500 patients with Budd\u2013Chiari syndrome.","volume":"32","author":"Hemachandran","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"R9-20260514","first-page":"1124","article-title":"Individualised endovascular treatment of Budd\u2013Chiari syndrome complicated by inferior vena cava thrombosis: 10 years follow-up study [in Chinese].","volume":"36","author":"Zhuang","year":"2020","journal-title":"J Pract Radiol"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.dld.2025.02.008","article-title":"Clinical characteristics and risk factors of hepatocellular carcinoma development in Budd\u2013Chiari syndrome patients after endovascular treatment.","volume":"57","author":"Huang","year":"2025","journal-title":"Dig Liver Dis"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ejh.14363","article-title":"Direct oral anticoagulants in Budd\u2013Chiari syndrome.","volume":"114","author":"Thapa","year":"2025","journal-title":"Eur J Haematol"},{"key":"R12-20260514","first-page":"614","article-title":"Epidemiological investigation of 1148 patients with Budd\u2013Chiari syndrome [in Chinese].","volume":"20","author":"Zhuang","year":"2011","journal-title":"China J Gen Surg"},{"key":"R13-20260514","doi-asserted-by":"crossref","first-page":"e23171","DOI":"10.1590\/s0004-2803.24612023-171","article-title":"Ten-year outcomes of tips for budd-chiari syndrome: systematic review and meta-analysis.","volume":"61","author":"Moreno","year":"2024","journal-title":"Arq Gastroenterol"},{"key":"R14-20260514","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12072-022-10464-y","article-title":"Establishment and validation of a prediction model for the first recurrence of Budd\u2013Chiari syndrome after endovascular treatment: a large sample size, single-center retrospective study.","volume":"17","author":"Wang","year":"2023","journal-title":"Hepatol Int"},{"key":"R15-20260514","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jech.2008.079640","article-title":"Comparison of methods for modelling a count outcome with excess zeros: application to activities of daily living (ADL-s).","volume":"65","author":"Zaninotto","year":"2011","journal-title":"J Epidemiol Community Health"},{"key":"R16-20260514","doi-asserted-by":"crossref","first-page":"5543977","DOI":"10.1155\/2021\/5543977","article-title":"Zero-inflated time series modelling of COVID-19 deaths in Ghana.","volume":"2021","author":"Tawiah","year":"2021","journal-title":"J Environ Public Health"},{"key":"R17-20260514","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.csbj.2023.02.027","article-title":"Infants\u2019 gut microbiome data: a Bayesian marginal zero-inflated negative binomial regression model for multivariate analyses of count data.","volume":"21","author":"Hajihosseini","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"R18-20260514","first-page":"156","article-title":"Budd\u2013Chiari syndrome: current state of the art [in Chinese].","volume":"26","author":"Deng","year":"2023","journal-title":"J Pract Hepatol"},{"key":"R19-20260514","first-page":"1229","article-title":"Expert consensus on the classification of subtype in Budd\u2013Chiari syndrome [in Chinese].","volume":"33","year":"2017","journal-title":"J Clin Hepatol"},{"key":"R20-20260514","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00330-016-4482-4","article-title":"Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd\u2013Chiari syndrome after stenting in China: a retrospective analysis of a large cohort.","volume":"27","author":"Li","year":"2017","journal-title":"Eur Radiol"},{"key":"R21-20260514","first-page":"2023.01.19.23284288","article-title":"Application of elastic net regression for modeling COVID-19 sociodemographic risk factors.","volume":"19","author":"Moxley","year":"2023","journal-title":"medRxiv"},{"key":"R22-20260514","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/met.2019.0104","article-title":"Logistic LASSO and elastic net to characterize vitamin D deficiency in a hypertensive obese population.","volume":"18","author":"Garcia-Carretero","year":"2020","journal-title":"Metab Syndr Relat Disord"},{"key":"R23-20260514","doi-asserted-by":"crossref","first-page":"20201157","DOI":"10.1259\/bjr.20201157","article-title":"Retrospective comparative study of efficacy, safety and outcome of percutaneous intervention for Budd\u2013Chiari syndrome patients with bilirubin less than 3 and 3\u20136\u2009mg\/dl.","volume":"94","author":"Patidar","year":"2021","journal-title":"Br J Radiol"},{"key":"R24-20260514","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2169\/internalmedicine.8020-21","article-title":"The albumin-bilirubin score detects changes in the liver function during treatment for Budd\u2013Chiari syndrome: a retrospective observational study.","volume":"61","author":"Kageyama","year":"2022","journal-title":"Intern Med"},{"key":"R25-20260514","first-page":"216","article-title":"A study on the factors influencing recurrence in patients with Budd\u2013Chiari syndrome [in Chinese].","volume":"37","author":"Zhang","year":"2017","journal-title":"J Xuzhou Med Univ"},{"key":"R26-20260514","first-page":"1377","article-title":"Analysis of risk factors for recurrence in patients with Budd\u2013Chiari syndrome complicated by thrombus in inferior vena cava after interventional therapy [in Chinese].","volume":"41","author":"Dang","year":"2021","journal-title":"Chin J Pract Surg"},{"key":"R27-20260514","first-page":"837","article-title":"Factors affecting thrombus fomation and efficacy of interventional therapy in patients with type II Budd\u2013Chiari syndrome [in Chinese].","volume":"28","author":"Gao","year":"2023","journal-title":"Chin Hepatol"},{"key":"R28-20260514","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2010.08.026","article-title":"Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd\u2013Chiari syndrome.","volume":"54","author":"Talens","year":"2011","journal-title":"J Hepatol"},{"key":"R29-20260514","first-page":"703","article-title":"Clinical character analysis of young Budd\u2013Chiari syndrome patients [in Chinese].","volume":"26","author":"Zhang","year":"2013","journal-title":"J Med Theory Pract"},{"key":"R30-20260514","first-page":"149","article-title":"Case-control study on biochemical indicators of Budd\u2013Chiari syndrome [in Chinese].","volume":"31","author":"Li","year":"2018","journal-title":"Med Inf"},{"key":"R31-20260514","first-page":"164","article-title":"Analysis of epidemiological and clinical characteristics of Budd\u2013Chiari syndrome in Northern Anhui [in Chinese].","volume":"1","author":"Gao","year":"2016","journal-title":"Chin J Vasc Surg"},{"key":"R32-20260514","first-page":"6","article-title":"Cost-effectiveness of new oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in low and middle-income countries: a systematic review.","volume":"36","author":"Souresrafil","year":"2022","journal-title":"Med J Islam Repub Iran"},{"key":"R33-20260514","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5578\/tt.20219908","article-title":"The use of new oral anticoagulants in geriatric patients: a survey study for physicians.","volume":"69","author":"Duru","year":"2021","journal-title":"Tuberk Toraks"},{"key":"R34-20260514","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/postgradmedj-2015-133402","article-title":"Budd\u2013Chiari syndrome: investigation, treatment and outcomes.","volume":"91","author":"Goel","year":"2015","journal-title":"Postgrad Med J"},{"key":"R35-20260514","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int"},{"key":"R36-20260514","first-page":"621","article-title":"Rivaroxaban as an oral anticoagulant in patients with Budd\u2013Chiari syndrome after percutaneous endovascular intervention [in Chinese].","volume":"24","author":"Li","year":"2021","journal-title":"J Pract Hepatol"},{"key":"R37-20260514","first-page":"593","article-title":"Safety of rivaroxaban in patients with decompensated cirrhosis [in Chinese].","volume":"43","author":"Du","year":"2021","journal-title":"Beijing Med J"},{"key":"R38-20260514","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.gastrohep.2020.06.028","article-title":"The outcomes of interventional treatment for Budd\u2013Chiari Syndrome complicated by inferior vena cava thrombosis: systematic review and meta-analysis.","volume":"44","author":"Sun","year":"2021","journal-title":"Gastroenterol Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:07:21Z","timestamp":1778756841000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":37,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045511","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-05-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}